H ypertension is one of the most common chronic diseases with complex pathogenesis. It is likely that hypertension is a consequence of an interaction between genetic and environmental factors. Although genome-wide association studies have identified multiple genes that are associated with hypertension, a great deal of our current understanding of the molecular mechanisms involved in blood pressure (BP) regulation 1 has come from analysis of the genes responsible for monogenetic syndromes of hypertension and hypotension. For example, loss-of-function mutations in the Na + /Cl − cotransporter (NCC; SLC12A3) causes Gitelman syndrome: patients are either normotensive or hypotensive with hypochloremic metabolic alkalosis and hypokalemia. [2][3][4][5] Increased NCC membrane expression resulting from either gain-of-function mutations with-no-lysine kinase 1 or loss-offunction mutations with-no-lysine kinase 4 leads to Gordon syndrome, characterized by salt-sensitive (SS) hypertension, hyperkalemia, and metabolic acidosis. 6,7 Loss-of-function mutations in Na− cotransporter (NKCC2, SLC12A1) or renal outer medullary potassium channel (ROMK, KCNJ1) are responsible for Bartter syndrome type I and type II, respectively. [8][9][10][11] These disorders are characterized by polyuria, salt wasting, hypokalemia, metabolic alkalosis, hypercalciuria, and hypotension. Furthermore, Ji et al 12 demonstrated that heterozygous mutations in all 3 of these genes, SLC12A3, SLC12A1, and KCNJ1, are associated with clinically significant BP reduction and protection from development of hypertension. Thus, these syndromes further underscore a key role of renal Abstract-The renal outer medullary potassium channel (ROMK, KCNJ1) mediates potassium recycling and facilitates sodium reabsorption through the Na + /K + /2Cl − cotransporter in the loop of Henle and potassium secretion at the cortical collecting duct. Human genetic studies indicate that ROMK homozygous loss-of-function mutations cause type II Bartter syndrome, featuring polyuria, renal salt wasting, and hypotension; humans heterozygous for ROMK mutations identified in the Framingham Heart Study have reduced blood pressure. ROMK null mice recapitulate many of the features of type II Bartter syndrome. We have generated an ROMK knockout rat model in Dahl salt-sensitive background by using zinc finger nuclease technology and investigated the effects of knocking out ROMK on systemic and renal hemodynamics and kidney histology in the Dahl salt-sensitive rats. The ROMK −/− pups recapitulated features identified in the ROMK null mice. The ROMK +/− rats, when challenged with a 4% salt diet, exhibited a reduced blood pressure compared with their ROMK +/+ littermates. More importantly, when challenged with an 8% salt diet, the Dahl salt-sensitive rats with 50% less ROMK expression showed increased protection from salt-induced blood pressure elevation and signs of protection from renal injury. Our findings in ROMK knockout Dahl salt-sensitive rats, together with the previous reports in humans and m...